Israeli ultrasound developer Insightec raises $22m

medical, medicine

The Haifa-based company is at the forefront of the global shift towards non-invasive procedures.

Israeli ultrasound developer Insightec has raised $22 million in Series D financing from current shareholders. Based in Haifa shareholders include Elbit Medical Technologies Ltd. (TASE: EMTC), York Capital, GE Healthcare, Medtech Advisors and a Chinese investor.

Founded in 1999, Insightec has developed MR-guided Focused Ultrasound (MRgFUS), a completely non-invasive therapy platform that transforms medicine in an expanding number of neurosurgery, oncology and gynecology indications. MRgFUS is already adopted and used by world recognized physicians in more than 120 leading medical facilities around the world, who see the tremendous clinical and economical value of the Insightec therapy platform.

Insightec also said it had appointed Dr. Maurice R. Ferré as CEO. He succeeds Dr. Kobi Vortman, the company founder, who takes a seat on the board and will continue to drive strategy, as well as the product roadmap.

Dr. Vortman founded the company 16 years ago in 1999. His vision was to create the next generation operating room by developing MRgFUS technology as an effective, non-invasive form of therapy.

Dr. Ferré said, "Insightec is at the forefront of the global shift towards non-invasive procedures. These procedures have the potential to improve patient outcomes, reduce morbidity and trauma while reducing costs."

Dr. Vortman said, " The company offers clinical applications in three clinical areas: Women's Health, Oncology and Neurosurgery, and has over 90 patents and many regulatory approvals.

Published by Globes [online], Israel business news - - on January 10, 2016

© Copyright of Globes Publisher Itonut (1983) Ltd. 2016

View comments in rows
Update by email about comments talkback
Your name
Please insert your name
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
medical, medicine
medical, medicine
Twitter Facebook Linkedin RSS Newsletters גלובס Capital  Markets Conference 2017